Antioxidant and neuroprotective properties of N-arachidonoyldopamine

Neuroscience Letters

Volumn 431, Issue 1, 2008, Pages 6-11

  Bobrov, Mikhail Yu ^a   Lizhin, Anatoly A ^b   Andrianova, Ekaterina L ^a   Gretskaya, Natalia M ^a   Frumkina, Lidia E ^b   Khaspekov, Leonid G ^b   Bezuglov, Vladimir V ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b RESEARCH CENTER OF NEUROLOGY   (Russian Federation)

Author keywords

Antioxidant; Cannabinoid; N Acyldopamine; N Arachidonoyldopamine; Neuroprotection; Vanilloid

Indexed keywords

5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ALPHA TOCOPHEROL; CANNABINOID RECEPTOR AGONIST; CAPSAZEPINE; N ACYLDOPAMINE; N ARACHIDONOYLDOPAMINE; N OLEOYLDOPAMINE; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; NERVE CELL; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; ARACHIDONIC ACIDS; BIOLOGICAL ASSAY; BRAIN; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; CYTOPROTECTION; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; MOLECULAR STRUCTURE; NEURONS; NEUROPROTECTIVE AGENTS; PEROXIDES; RATS; RATS, WISTAR;

EID: 38049021125     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.11.010     Document Type: Article

References (29)

1. 2+ exchange enhances delayed neuronal death elicited by glutamate in cerebellar granule cell cultures. Brain Res. 548 (1991) 322-325
2. Bezuglov V.V., Manevich E.M., Archakov A.V., Bobrov M.Iu., Kuklev D.V., Petrukhina G.N., Makarov V.A., and Buznikov G.A. Artificially functionalized polyenoic fatty acids-a new lipid bioregulators. Bioorg. Khim. 23 (1997) 211-220
3. Bezuglov V.V., Bobrov M.Yu., Gretskaya N.M., Gonchar A.A., Zinchenko G.N., Melck D., Bisogno T., Di Marzo V., Kuklev D.V., Rossi J.C., Vidal J.P., and Durand T. Synthesis and biological evaluation of novel amides of polyunsaturated fatty acids with dopamine. Bioorg. Med. Chem. Lett. 11 (2001) 447-449
4. Bisogno T., Melck D., Bobrov M.Yu., Gretskaya N.M., Bezuglov V.V., De Petrocellis L., and Di Marzo V. N-Acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. Biochem. J. 351 (2000) 817-824
5. Carrier E.J., Patel S., and Hillard C.J. Endocannabinoids in neuroimmunology and stress. Curr. Drug Targets CNS Neurol. Disord. 4 (2005) 657-665
6. Castilho R.F., Ward M.W., and Nicholls D.G. Oxidative stress, mitochondrial function, and acute glutamate excitotoxicity in cultured cerebellar granule cells. J. Neurochem. 72 (1999) 1394-1401
7. Chu C.J., Huang S.M., De Petrocellis L., Bisogno T., Ewing S.A., Miller J.D., Zipkin R.E., Daddario N., Appendino G., Di Marzo V., and Walker J.M. N-Oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. J. Biol. Chem. 278 (2003) 13633-13639
8. Daily D., Barzilai A., Offen D., Kamsler A., Melamed E., and Ziv I. The involvement of p53 in dopamine-induced apoptosis of cerebellar granule neurons and leukemic cells overexpressing p53. Cell Mol. Neurobiol. 19 (1999) 261-276
9. D'Mello S.R., Galli C., Ciotti T., and Calissano P. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 10989-10993
10. Gay C.A., and Gebicki J.M. Perchloric Acid Enhances sensitivity and reproducibility of the ferric-xylenol orange peroxide assay. Anal. Biochem. 304 (2002) 42-46
11. Graham D.G. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14 (1978) 633-643
12. Huang S.M., Bisogno T., Trevisani M., Al-Hayani A., De Petrocellis L., Fezza F., Tognetto M., Petros T.J., Krey J.F., Chu C.J., Miller J.D., Davies S.N., Geppetti P., Walker J.M., and Di Marzo V. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 8400-8405
13. Li S.W., Lin T.S., Minteer S., and Burke W.J. 3,4-Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson's disease pathogenesis. Brain. Res. Mol. Brain. Res. 93 (2001) 1-7
14. Marsicano G., Moosmann B., Hermann H., Lutz B., and Behl C. Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. J. Neurochem. 80 (2002) 448-456
15. Osakada F., Hashino A., Kume T., Katsuki H., Kaneko S., and Akaike A. Neuroprotective effects of a-tocopherol on oxidative stress in rat striatal cultures. Eur. J. Pharmacol. 465 (2003) 15-22
16. Oxenkrug G.F., and Requintina P.J. N-Acetyldopamine inhibits rat brain lipid peroxidation induced by lipopolysaccharide. Ann. N. Y. Acad. Sci. 1053 (2005) 394-399
17. Pazos M.R., Nunez E., Benito C., Tolon R.M., and Romero J. Functional neuroanatomy of the endocannabinoid system. Pharmacol. Biochem. Behav. 81 (2005) 239-247
18. Ray A.M., Benham C.D., Roberts J.C., Gill C.H., Lanneau C., Gitterman D.P., Harries M., Davis J.B., and Davies C.H. Capsazepine protects against neuronal injury caused by oxygen glucose deprivation by inhibiting I(h). J. Neurosci. 23 (2003) 10146-10153
19. Sancho R., Macho A., de La Vega L., Calzado M.A., Fiebich B.L., Appendino G., and Munoz E. Immunosuppressive activity of endovanilloids: N-arachidonoyl-dopamine inhibits activation of the NF-kappaB, NFAT, and activator protein 1 signaling pathways. J. Immunol. 172 (2004) 2341-2351
20. Sancho R., de la Vega L., Macho A., Appendino G., Di Marzo V., and Munoz E. Mechanisms of HIV-1 inhibition by the lipid mediator N-arachidonoyldopamine. Immunology 175 (2005) 3990-3999
21. Shashoua V.E., and Hesse G.W. N-Docosahexaenoyl-3-hydroxytyramine: a dopaminergic compound that penetratesthe blood-brain barrier and suppresses appetite. Life Sci. 58 (1996) 1347-1357
22. Shi H., and Niki E. Stoichiometric and kinetic studies on Ginko biloba extract and related antioxidants. Lipids 33 (1998) 365-370
23. Sugawara T., Fujimura M., Noshita N., Kim G.W., Saito A., Hayashi T., Narasimhan P., Maier C.M., and Chan P.H. Neurorx 1 (2004) 17-25
24. Toth A., Kedei N., Wang Y., and Blumberg P.M. Arachidonyl dopamine as a ligand for the vanilloid receptor VR1 of the rat. Life Sci. 73 (2003) 487-498
25. Tseng C.F., Iwakami S., Mikajiri A., Shibuya M., Hanaoka F., Ebizuka Y., Padmawinata K., and Sankawa U. Inhibition of in vitro prostaglandin and leukotriene biosyntheses by cinnamoyl-beta-phenethylamine and N-acyldopamine derivatives. Chem. Pharm. Bull. (Tokyo) 40 (1992) 396-400
26. Valencia A., and Moran J. Role of oxidative stress in the apoptotic cell death of cultured cerebellar granule neurons. J. Neurosci. Res. 64 (2001) 284-297
27. Vasil'eva T.M., Petrukhina G.N., Makarov V.A., Miftakhova N.T., Khailov N.A., Gan'shina T.S., Mirzoian R.S., Gretskaia N.M., Bobrov M.Iu., and Bezuglov V.V. Effect of dopamineamides of polyunsaturated fatty acids on blood coagulation system and cerebral circulation. Eksp. Klin. Farmakol. 65 (2002) 41-45
28. Veldhuis W.B., van der Stelt M., Wadman M.W., van Zadelhoff G., Maccarrone M., Fezza F., Veldink G.A., Vliegenthart J.F., Bar P.R., Nicolay K., and Di Marzo V. Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases. J. Neurosci. 23 (2003) 4127-4133
29. Yen G.C., and Hsieh C.L. Antioxidant effects of dopamine and related compounds. Biosci. Biotechnol. Biochem. 61 (1997) 1646-1649